Skip to content
AMZN$271.15+5.12(+1.92%)Amazon: An Earnings Supercycle Is Taking Shape8:38:41 AM ETNVDA$197.27-3.02(-1.51%)Chinese AI lab Moonshot turned to Europe for Nvidia Blackwell access amid U.S. China curbs, sources tell CNBC8:34:14 AM ETHRL$22.98+0.22(+0.97%)3 Dividend Aristocrats Trading Below Their Historical Valuations8:34:12 AM ETTSM$385.20-10.42(-2.63%)TSMC's AI Opportunity Is Expanding. Here's the Question That Matters for Its Stock Price8:33:37 AM ETHD$359.57+4.13(+1.16%)Three Days, 36 Hands-On Workshop Sessions and HGTV's Biggest Stars: Here's What's Happening Each Day at the First-Ever DIY CON November 6-88:33:00 AM ETMCD$281.50+1.28(+0.46%)McDonald's Q3: 11% EPS Growth And A 50% Operating Margin Say The Sell-Off Was A Mistake8:30:51 AM ETTMO$711.10+4.94(+0.70%)Thermo Fisher Scientific Introduces Value-Priced Thermo Scientific™ AmpSure™ Universal qPCR Master Mixes Without Compromising Performance8:30:16 AM ETAAPL$353.45+3.94(+1.13%)Apple Stock Is Up 22%, but 1 Slowing Business Could Test That Valuation8:30:00 AM ETBRK-A$881,000.00+11,699.24(+1.35%)Two in three US-listed companies pay no dividend, a census of SEC filings finds8:30:00 AM ETTEAD$0.20-0.07(-25.93%)Ad platform Teads misses Q3 revenue estimates; suspends guidance8:29:01 AM ETC$126.33+1.56(+1.25%)UPDATE 6-Oil rises as investors weigh uncertainties around Iran war8:27:07 AM ETMCD$281.50+1.28(+0.46%)McDonald's To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Thursday8:22:06 AM ETMRNA$256.00-2.34(-0.91%)Moderna, Humana and Elanco Earnings Previews: What Investors Should Watch8:18:32 AM ETQCOM$153.70-19.49(-11.25%)Qualcomm: The AI Boom's Biggest Casualty8:18:20 AM ETAMD$462.81-25.97(-5.31%)AMD: The Bigger Earnings Opportunity Starts In 20278:17:47 AM ETV$440.50+3.91(+0.90%)Visa Just Raised Its Dividend 16%. Is It a Better Buy Than Mastercard?8:17:32 AM ETCVS$80.65+0.66(+0.83%)RPT-BREAKINGVIEWS-CVS’s problem: investors trust the warning label8:16:38 AM ETCOP$139.38+2.44(+1.78%)STAK Energy Signs Long-Term Agreement to Bring North Slope Natural Gas to Market8:15:00 AM ETMU$756.59-38.87(-4.89%)Is Micron stock a Buy after crashing below $800?8:13:57 AM ETGOOG$290.58+3.28(+1.14%)Meta Paid 1.4 Times What Alphabet Did to Borrow in Euros8:08:00 AM ETCOP$139.38+2.44(+1.78%)ConocoPhillips Profit Rises as Oil Prices Climb8:06:00 AM ETTCPC$4.30-0.08(-1.83%)BlackRock TCP Capital Corp. Announces Third Quarter 2026 Financial Results Including Net Investment Income of $0.16 Per Share; Declares a Fourth Quarter Dividend of $0.17 Per Share8:05:07 AM ETINTC$56.83-1.45(-2.49%)Intel: I Warned Before The 40% Crash, Now I'm Bullish (Rating Upgrade)8:05:00 AM ETASML$1,454.42-41.72(-2.79%)Could $10,000 Invested in ASML Set You Up for Life?8:05:00 AM ET

CRON · NASDAQ

Cronos Group Inc.

$3.67 +0.15 (+4.41%)

Company overview

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-consumer channels under its wellness platform, PEACE NATURALS, and operates under the adult-use brand Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Market cap
$1.4B
Employees
459
Headquarters
Stayner, ON
CEO
Michael Ryan Gorenstein
Listed
February 27, 2018
P/E
-1,835.00
Dividend yield
0.00%

Company financials

Revenue
$206M
Gross profit
$67.5M
Operating income
-$291,845
EBITDA
-$12.1M
Net income
-$2M
EPS
-$0.00
Total assets
$1.2B
Total debt
$1.3M
Gross margin
32.81%
Net margin
-0.98%
Earnings yield
-0.05%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

2.482.773.063.363.65
CRON 1D NASDAQ O3.45H3.57L3.44C3.52+0.14 (+3.99%)Vol2.01M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
CRONCronos Group Inc. Stock news Canada's Cronos Q3 revenue up 75% on cannabis flower demand in Israel, Germany Reuters
CRONCronos Group Inc. Stock news BRIEF-Cronos Group Q3 Net Income USD 17.8 Million Reuters
CRONCronos Group Inc. Press release Cronos Group Reports 2026 Third Quarter Results GlobeNewswire
CRONCronos Group Inc. Stock news Baker Hughes Wins Major Subsea Contract From Eni for Cronos Gas Zacks Investment Research
CRONCronos Group Inc. Press release Baker Hughes Wins Significant Subsea Production Systems and Services Award for Eni’s Cronos Gas Development GlobeNewswire
CRONCronos Group Inc. Stock news Are Medical Stocks Lagging Cronos Group (CRON) This Year? Zacks Investment Research
CRONCronos Group Inc. Stock news Cronos (CRON) Upgraded to Strong Buy: Here's What You Should Know Zacks Investment Research
CRONCronos Group Inc. Press release Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company GlobeNewswire
CRONCronos Group Inc. Press release Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season GlobeNewswire
CRONCronos Group Inc. Press release Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026 GlobeNewswire
CRONCronos Group Inc. Stock news Financial Survey: Eton Pharmaceuticals (NASDAQ:ETON) vs. Cronos Group (NASDAQ:CRON) Defense World
CRONCronos Group Inc. Stock news Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions MarketBeat
CRONCronos Group Inc. Press release Cronos Hosts 2026 Investor Day GlobeNewswire
CRONCronos Group Inc. Stock news Head to Head Contrast: Lyra Therapeutics (OTCMKTS:LYRA) versus Cronos Group (NASDAQ:CRON) Defense World
CRONCronos Group Inc. Stock news Cronos: Invest In Cannabis With 50% Net Cash And GAAP Profitability Seeking Alpha
CRONCronos Group Inc. Press release Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario GlobeNewswire
CRONCronos Group Inc. Stock news Are Medical Stocks Lagging Cronos Group (CRON) This Year? Zacks Investment Research
CRONCronos Group Inc. Press release Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes GlobeNewswire
CRONCronos Group Inc. Stock news 4 Healthcare Stocks to Safeguard Your Portfolio as Fed Plans Rate Hike Zacks Investment Research
CRONCronos Group Inc. Stock news Mercury Systems Posts Mixed Q4 Results, Joins WhiteFiber And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Benzinga
FAQ

Questions about Cronos Group Inc.

What does Cronos Group Inc. do?
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-consumer channels under its wellness platform, PEACE NATURALS, and operates under the adult-use brand Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
What is CRON's market cap?
Cronos Group Inc. (CRON) is a listed stock with a live quote. The latest market cap on this page is $1.4B.
Where is Cronos Group Inc. headquartered?
Cronos Group Inc. is headquartered in Stayner, ON.
How do I get CRON news from the API?
Call GET /v1/news?tickers=CRON. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does CRON news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for CRON, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the CRON price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.